Daibetes
-
{
- All
- News
-
Frequent Urination In Men: Early Sign Of Diabetes Or Prostate Issue?
- Friday April 10, 2026
- Health | Written by Sambhav Kumar
Frequent urination is one of the early and most common symptoms of Type 2 Diabetes. When blood sugar levels rise, the kidneys work harder to filter and remove excess glucose from the body.
-
www.ndtv.com
-
GLP-1 Drugs In India: How To Spot Fakes Before It's Too Late
- Monday March 30, 2026
- Health | Written by Sambhav Kumar
Counterfeit GLP-1 drugs like semaglutide are rising in India amid growing demand and multiple cheaper versions entering the market.
-
www.ndtv.com
-
Telangana's Mega Health Drive Flags 26.9 Lakh With High Blood Pressure, 14 Lakh With Diabetes
- Wednesday March 25, 2026
- Health | Written by Sambhav Kumar
Hypertension and diabetes are popularly known as "silent killers" because they may not show obvious symptoms until serious complications develop.
-
www.ndtv.com
-
Affordable Semaglutide Is Coming: Should You Be Worried About Drug Safety, Health Risks And Side Effects?
- Thursday March 19, 2026
- Health | Written by Sambhav Kumar
India's healthcare landscape will change as semaglutide patents expire in 2026, allowing over 50 generic versions to enter the market and improve access for diabetes and obesity treatment.
-
www.ndtv.com
-
What Are Semaglutide Generics? Here's Why They Matter More In India Now
- Tuesday March 17, 2026
- Health | Written by Sambhav Kumar
Semaglutide works by imitating the natural hormone glucagon-like peptide-1 (GLP-1), which plays a key role in managing blood sugar.
-
www.ndtv.com
-
No Warning Signs: Why Kidney Disease From High BP And Diabetes Often Goes Unnoticed
- Monday March 16, 2026
- Health | Written by Sambhav Kumar
For individuals with high blood pressure or diabetes, regular health check-ups are essential for early detection of kidney problems.
-
www.ndtv.com
-
50+ Branded Semaglutide Generics To Enter India As Diabetes Drug Patent Expires In March 2026
- Monday March 16, 2026
- Health | Written by Sambhav Kumar
Semaglutide patent in India expires in March 2026, enabling over 50 branded generic versions to enter the market, likely reducing treatment costs for diabetes and obesity patients.
-
www.ndtv.com
-
Frequent Urination In Men: Early Sign Of Diabetes Or Prostate Issue?
- Friday April 10, 2026
- Health | Written by Sambhav Kumar
Frequent urination is one of the early and most common symptoms of Type 2 Diabetes. When blood sugar levels rise, the kidneys work harder to filter and remove excess glucose from the body.
-
www.ndtv.com
-
GLP-1 Drugs In India: How To Spot Fakes Before It's Too Late
- Monday March 30, 2026
- Health | Written by Sambhav Kumar
Counterfeit GLP-1 drugs like semaglutide are rising in India amid growing demand and multiple cheaper versions entering the market.
-
www.ndtv.com
-
Telangana's Mega Health Drive Flags 26.9 Lakh With High Blood Pressure, 14 Lakh With Diabetes
- Wednesday March 25, 2026
- Health | Written by Sambhav Kumar
Hypertension and diabetes are popularly known as "silent killers" because they may not show obvious symptoms until serious complications develop.
-
www.ndtv.com
-
Affordable Semaglutide Is Coming: Should You Be Worried About Drug Safety, Health Risks And Side Effects?
- Thursday March 19, 2026
- Health | Written by Sambhav Kumar
India's healthcare landscape will change as semaglutide patents expire in 2026, allowing over 50 generic versions to enter the market and improve access for diabetes and obesity treatment.
-
www.ndtv.com
-
What Are Semaglutide Generics? Here's Why They Matter More In India Now
- Tuesday March 17, 2026
- Health | Written by Sambhav Kumar
Semaglutide works by imitating the natural hormone glucagon-like peptide-1 (GLP-1), which plays a key role in managing blood sugar.
-
www.ndtv.com
-
No Warning Signs: Why Kidney Disease From High BP And Diabetes Often Goes Unnoticed
- Monday March 16, 2026
- Health | Written by Sambhav Kumar
For individuals with high blood pressure or diabetes, regular health check-ups are essential for early detection of kidney problems.
-
www.ndtv.com
-
50+ Branded Semaglutide Generics To Enter India As Diabetes Drug Patent Expires In March 2026
- Monday March 16, 2026
- Health | Written by Sambhav Kumar
Semaglutide patent in India expires in March 2026, enabling over 50 branded generic versions to enter the market, likely reducing treatment costs for diabetes and obesity patients.
-
www.ndtv.com